Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lehrnbecher

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
Current Opinion in Pediatrics|November 22, 2018
Treatment of fever in neutropenia in pediatric oncology patientsThomas Lehrnbecher
Expert Review of Anti-Infective Therapy|June 1, 2019
The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantationThomas Lehrnbecher
Current Opinion in Infectious Diseases|September 19, 2015
Antifungal prophylaxis in pediatric patients undergoing therapy for cancer: drugs and dosingThomas Lehrnbecher
Pharmazie in Unserer Zeit|July 31, 2012
[Infectious complications in acute lymphoblastic leukemia: Individually tailored prevention and treatment]Thomas Lehrnbecher
Expert Review of Hematology|November 1, 2014
Anti-infective prophylaxis in pediatric patients with acute myeloid leukemiaThomas Lehrnbecher, Lillian Sung
Current Fungal Infection Reports|July 7, 2017
Progress in the Diagnosis of Invasive Fungal Disease in ChildrenAdilia Warris, Thomas Lehrnbecher
British Journal of Haematology|February 14, 2002
Haematopoietic growth factors in children with neutropeniaThomas Lehrnbecher, Karl Welte
Medical Mycology|March 1, 2019
Why are natural killer cells important for defense against Aspergillus?Thomas Lehrnbecher, Stanislaw Schmidt
Expert Review of Hematology|November 19, 2010
Myeloid growth factors as anti-infective measures in children with leukemia and lymphomaThomas Lehrnbecher, Ursula Creutzig
Pediatric Blood & Cancer|June 29, 2010
Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patientsThomas Lehrnbecher, Andreas H Groll
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Current Opinion in Pediatrics|November 22, 2018
Treatment of fever in neutropenia in pediatric oncology patientsThomas Lehrnbecher
Expert Review of Anti-Infective Therapy|June 1, 2019
The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantationThomas Lehrnbecher
Current Opinion in Infectious Diseases|September 19, 2015
Antifungal prophylaxis in pediatric patients undergoing therapy for cancer: drugs and dosingThomas Lehrnbecher
Pharmazie in Unserer Zeit|July 31, 2012
[Infectious complications in acute lymphoblastic leukemia: Individually tailored prevention and treatment]Thomas Lehrnbecher
Expert Review of Hematology|November 1, 2014
Anti-infective prophylaxis in pediatric patients with acute myeloid leukemiaThomas Lehrnbecher, Lillian Sung
Current Fungal Infection Reports|July 7, 2017
Progress in the Diagnosis of Invasive Fungal Disease in ChildrenAdilia Warris, Thomas Lehrnbecher
British Journal of Haematology|February 14, 2002
Haematopoietic growth factors in children with neutropeniaThomas Lehrnbecher, Karl Welte
Medical Mycology|March 1, 2019
Why are natural killer cells important for defense against Aspergillus?Thomas Lehrnbecher, Stanislaw Schmidt
Expert Review of Hematology|November 19, 2010
Myeloid growth factors as anti-infective measures in children with leukemia and lymphomaThomas Lehrnbecher, Ursula Creutzig
Pediatric Blood & Cancer|June 29, 2010
Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patientsThomas Lehrnbecher, Andreas H Groll
Pageof 24